Significance of increased scrotal Tc-99m MDP uptake in patients with prostate cancer

被引:4
|
作者
Selcuk, Nalan Alan [1 ]
Sayman, Haluk B. [2 ]
Kanmaz, Bedii [2 ]
Turkmen, Cuneyt [3 ]
Selcuk, Hakan [4 ]
Nisli, Cavit [2 ]
Uslu, Ilhami [2 ]
机构
[1] Yeditepe Univ, Sch Med, Dept Nucl Med, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Dept Nucl Med, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Nucl Med, Istanbul, Turkey
[4] Bakirkoy State Hosp, Dept Radiol, Istanbul, Turkey
关键词
bone scintigraphy; prostate cancer; scrotal uptake technetium-99m methylene diphosphonate; THROMBOEMBOLIC DISEASE; THROMBOSIS;
D O I
10.1097/MNM.0b013e328341a75c
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective We observed an unusually increased scrotal uptake as an interesting finding in some patients with prostate cancer who were scanned for any possible metastatic disease. This study was designed to investigate the significance of this incidental finding in the technetium-99m methylene diphosphonate scintigraphies. Methods The study population consisted of 104 patients with biopsy-proven prostate cancer (group I), 55 male patients with other cancers (group II), 30 male patients with nonmalignant diseases (group III) and finally 15 patients with benign prostate hypertrophy (group IV). The square-shaped regions of interest are placed centrally on the scrotum and then on the lateral femoral soft tissue. Then the simple ratios of the scrotal and femoral soft tissue mean counts (S/Bg) were calculated. The statistical significance of differences among the groups in terms of scrotal uptake was determined. Results Group I showed increased scrotal uptake relative to the other groups. The mean uptake ratios (S/Bg +/- standard deviation) were 3.49 +/- 1.42 in group I, 2.89 +/- 0.70 in group II, 2.87 +/- 0.75 in group III, and 2.91 +/- 0.60 in group IV. This ratio was significantly higher in patients with prostate cancer than the normal group (P=0.024), the group with benign prostate hypertrophy (P=0.004), and the patients with other cancers (P=0.004). Conclusion Our results showed that technetium-99m methylene diphosphonate bone scintigraphy, as a routine for detecting metastatic disease or performed for other purposes, could give clues for a hidden prostate cancer. Then, in elderly male patients, we strongly recommend that it is wise to keep one's eye on scrotal activity when bone scans are read and where there is any doubt, take appropriate regions of interest to make quantitative evaluations. Nucl Med Commun 32:155-158 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins. Nuclear Medicine Communications 2011, 32:155-158
引用
收藏
页码:155 / 158
页数:4
相关论文
共 50 条
  • [1] TC-99M MDP UPTAKE IN HEPATOBLASTOMA
    ELGAZZAR, AH
    JAHAN, S
    MOTAWEI, S
    ABDELDAYEM, HM
    CLINICAL NUCLEAR MEDICINE, 1989, 14 (02) : 143 - 143
  • [2] TC-99M MDP UPTAKE IN OSTEOPOIKILOSIS
    MUNGOVAN, JA
    TUNG, GA
    LAMBIASE, RE
    NOTO, RB
    DAVIS, RP
    CLINICAL NUCLEAR MEDICINE, 1994, 19 (01) : 6 - 8
  • [3] UPTAKE OF TC-99M MDP BY HEPATOBLASTOMA
    CORY, DA
    SIDDIQUI, AR
    COHEN, MD
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1987, 12 (11): : 546 - 547
  • [4] SOFT-TISSUE UPTAKE OF TC-99M MDP IN SECONDARY SCROTAL LYMPHEDEMA
    RAO, BR
    HODGENS, DW
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (03) : 275 - 275
  • [5] TC-99M MDP SCROTAL IMAGE TESTICULAR AMYLOIDOSIS
    STY, JR
    STARSHAK, RJ
    CLINICAL NUCLEAR MEDICINE, 1983, 8 (03) : 142 - 142
  • [6] Decreased Tc-99m MDP uptake in myelonecrosis
    Kekilli, E
    Yagmur, C
    Kaya, E
    Kuku, I
    Ertem, K
    Aydogdu, I
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (01) : 33 - 33
  • [7] Tc-99m MDP uptake in uterine leiomyoma
    Teixeira, ABMJ
    Etchebehere, ECSC
    Carvalho, DC
    Sousa, MCM
    Santos, AO
    Lima, MCL
    Ramos, CD
    Camargo, EE
    CLINICAL NUCLEAR MEDICINE, 2000, 25 (06) : 484 - 484
  • [8] Tc-99m MDP Uptake in Retroperitoneal Fibrosis
    Zhang, Weifang
    Zhang, Yanyan
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (03) : 189 - 190
  • [9] TC-99M MDP UPTAKE IN A CEREBRAL INFARCT
    LOW, RD
    HICKS, RJ
    GILL, G
    ARKLES, LB
    CLINICAL NUCLEAR MEDICINE, 1992, 17 (12) : 968 - 970
  • [10] TC-99M MDP UPTAKE IN A CASE OF HEPATOBLASTOMA
    CORY, DA
    SIDDIQUI, AR
    COHEN, MD
    CLINICAL NUCLEAR MEDICINE, 1989, 14 (09) : 720 - 720